Physician profile
Andrew Cole
NPI 1336111665
$14,860.35
in general payments reported to CMS, 2019-2025
45 companies · $2,298 in 2025
The $2,298 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $963 · 2020: $571 · 2021: $1,182 · 2022: $2,503 · 2023: $3,620 · 2024: $3,723 · 2025: $2,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,021 · Food and Beverage: $1,794 · Travel and Lodging: $575 · Education: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,021.00 |
| Food and Beverage | $1,794.14 |
| Travel and Lodging | $574.99 |
| Education | $250.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $8,647.83 | 2021-2025 | Nexplanon, Jada System |
| Abbvie INC. | $789.65 | 2019-2025 | Lo Loestrin Fe |
| Medtronic, INC. | $540.96 | 2022-2025 | Interstim |
| Minerva Surgical, INC | $487.37 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $460.50 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $407.95 | 2021-2025 | |
| Astellas Pharma US INC | $393.52 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $344.91 | 2019-2025 | |
| Intuitive Surgical, INC. | $319.87 | 2021-2025 | Da Vinci Surgical System |
| Exeltis, USA INC. | $268.78 | 2020-2025 | Slynd |
| Biogen, INC. | $217.23 | 2024-2025 | Zurzuvae |
| Allergan, INC. | $167.65 | 2019-2022 | |
| Evofem Biosciences, INC. | $161.21 | 2021-2022 | |
| Avion Pharmaceuticals | $158.25 | 2020-2022 | |
| Hologic Sales and Service, LLC | $146.80 | 2019-2025 | Aptima |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $128.10 | 2019-2022 | |
| Baxter Healthcare | $106.00 | 2020 | |
| Sumitomo Pharma America, INC. | $102.36 | 2023-2025 | Gemtesa, Myfembree |
| Shield Therapeutics INC | $92.21 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $91.04 | 2019-2022 | |
| Therapeuticsmd, INC. | $80.05 | 2019-2022 | |
| Amgen INC. | $76.90 | 2019-2021 | |
| Duchesnay USA Incorporated | $75.06 | 2019 | |
| Aspira Women'S Health INC | $56.02 | 2021-2022 | |
| Smith+Nephew, INC. | $54.47 | 2021-2025 | Stravix |
| Millicent US INC | $45.80 | 2025 | Intrarosa, Femlyv |
| Coloplast Corp | $38.41 | 2020-2024 | |
| Myovant Sciences INC. | $37.95 | 2022 | |
| Ethicon US, LLC | $37.70 | 2019-2020 | |
| Baudax Bio INC. | $32.78 | 2020-2021 | |
| Innovation Technologies INC | $32.32 | 2025 | Irrisept |
| Urovant Sciences INC | $29.74 | 2021-2022 | |
| Lilly USA, LLC | $27.24 | 2022-2023 | Emgality, Reyvow |
| Davol INC. | $25.21 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $21.56 | 2023 | Exparel |
| Radius Health, INC. | $19.00 | 2022 | |
| Mimedx Group, INC. | $18.63 | 2024 | |
| Medline Industries LP | $17.91 | 2022 | |
| Becton, Dickinson and Company | $17.31 | 2019 | |
| Dexcom, INC. | $16.06 | 2025 | Dexcom G6 Transmitter |
| Eisai INC. | $15.09 | 2020 | |
| Glaxosmithkline, LLC. | $14.96 | 2021 | |
| Meditrina | $13.62 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.48 | 2019 | |
| Lupin INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.